ITCI
Price
$76.82
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
One day until earnings call
NBIX
Price
$116.20
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
One day until earnings call
Ad is loading...

ITCI vs NBIX

Header iconITCI vs NBIX Comparison
Open Charts ITCI vs NBIXBanner chart's image
Intra-Cellular Therapies
Price$76.82
Change-$0.00 (-0.00%)
Volume$650.92K
CapitalizationN/A
Neurocrine Biosciences
Price$116.20
Change-$0.00 (-0.00%)
Volume$676.28K
CapitalizationN/A
View a ticker or compare two or three
ITCI vs NBIX Comparison Chart
Loading...
ITCI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
ITCI vs. NBIX commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITCI is a Buy and NBIX is a Buy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (ITCI: $76.82 vs. NBIX: $116.20)
Brand notoriety: ITCI: Notable vs. NBIX: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ITCI: 124% vs. NBIX: 69%
Market capitalization -- ITCI: $6.7B vs. NBIX: $13.72B
ITCI [@Pharmaceuticals: Other] is valued at $6.7B. NBIX’s [@Pharmaceuticals: Other] market capitalization is $13.72B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITCI’s FA Score shows that 1 FA rating(s) are green whileNBIX’s FA Score has 0 green FA rating(s).

  • ITCI’s FA Score: 1 green, 4 red.
  • NBIX’s FA Score: 0 green, 5 red.
According to our system of comparison, ITCI is a better buy in the long-term than NBIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITCI’s TA Score shows that 6 TA indicator(s) are bullish while NBIX’s TA Score has 4 bullish TA indicator(s).

  • ITCI’s TA Score: 6 bullish, 3 bearish.
  • NBIX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ITCI is a better buy in the short-term than NBIX.

Price Growth

ITCI (@Pharmaceuticals: Other) experienced а -0.12% price change this week, while NBIX (@Pharmaceuticals: Other) price change was -0.32% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

ITCI is expected to report earnings on Feb 26, 2025.

NBIX is expected to report earnings on Feb 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBIX($13.7B) has a higher market cap than ITCI($6.7B). ITCI YTD gains are higher at: 7.261 vs. NBIX (-11.809). NBIX has higher annual earnings (EBITDA): 358M vs. ITCI (-158.85M). NBIX has more cash in the bank: 1.03B vs. ITCI (498M). ITCI has less debt than NBIX: ITCI (16.9M) vs NBIX (428M). NBIX has higher revenues than ITCI: NBIX (1.89B) vs ITCI (462M).
ITCINBIXITCI / NBIX
Capitalization6.7B13.7B49%
EBITDA-158.85M358M-44%
Gain YTD7.261-11.809-61%
P/E RatioN/A57.20-
Revenue462M1.89B24%
Total Cash498M1.03B48%
Total Debt16.9M428M4%
FUNDAMENTALS RATINGS
ITCI vs NBIX: Fundamental Ratings
ITCI
NBIX
OUTLOOK RATING
1..100
1210
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
74
Overvalued
PROFIT vs RISK RATING
1..100
860
SMR RATING
1..100
9356
PRICE GROWTH RATING
1..100
4861
P/E GROWTH RATING
1..100
10092
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ITCI's Valuation (58) in the Biotechnology industry is in the same range as NBIX (74). This means that ITCI’s stock grew similarly to NBIX’s over the last 12 months.

ITCI's Profit vs Risk Rating (8) in the Biotechnology industry is somewhat better than the same rating for NBIX (60). This means that ITCI’s stock grew somewhat faster than NBIX’s over the last 12 months.

NBIX's SMR Rating (56) in the Biotechnology industry is somewhat better than the same rating for ITCI (93). This means that NBIX’s stock grew somewhat faster than ITCI’s over the last 12 months.

ITCI's Price Growth Rating (48) in the Biotechnology industry is in the same range as NBIX (61). This means that ITCI’s stock grew similarly to NBIX’s over the last 12 months.

NBIX's P/E Growth Rating (92) in the Biotechnology industry is in the same range as ITCI (100). This means that NBIX’s stock grew similarly to ITCI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ITCINBIX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
60%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bullish Trend 2 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
65%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
71%
Declines
ODDS (%)
Bearish Trend 27 days ago
73%
Bearish Trend 21 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 7 days ago
74%
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
ITCI
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NBIX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

ITCI and

Correlation & Price change

A.I.dvisor tells us that ITCI and ACET have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ITCI and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITCI
1D Price
Change %
ITCI100%
+1.33%
ACET - ITCI
32%
Poorly correlated
+2.14%
AVDL - ITCI
31%
Poorly correlated
-0.62%
SXTC - ITCI
29%
Poorly correlated
+2.61%
SUPN - ITCI
25%
Poorly correlated
+0.68%
PRGO - ITCI
24%
Poorly correlated
+2.71%
More

NBIX and

Correlation & Price change

A.I.dvisor tells us that NBIX and ACET have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NBIX and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBIX
1D Price
Change %
NBIX100%
+0.10%
ACET - NBIX
25%
Poorly correlated
+2.14%
AVDL - NBIX
23%
Poorly correlated
-0.62%
SNDL - NBIX
23%
Poorly correlated
+1.38%
IMCC - NBIX
23%
Poorly correlated
-1.49%
ZOM - NBIX
23%
Poorly correlated
+1.82%
More